The efficacy and safety of ε-aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 1, 2006, Pages 115-120

  Gunawan, B ^a   Runyon, B ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; SERUM GLOBULIN;

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INDICATION; DRUG SAFETY; EUGLOBULIN LYSIS TEST; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER HYPERFIBRINOLYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SOFT TISSUE DISEASE; SUBCUTANEOUS HEMORRHAGE; THROMBOEMBOLISM; TREATMENT OUTCOME; DRUG EFFECT; FIBRINOLYSIS; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RETROSPECTIVE STUDY;

6-AMINOCAPROIC ACID; ADMINISTRATION, ORAL; ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; FEMALE; FIBRINOLYSIS; HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SERUM GLOBULINS;

EID: 33644884758     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02730.x     Document Type: Article

References (32)

1. Hu KQ Yu AS Tiyyagura L et al. Hyperfibrinolyitc activity in hospitalized cirrhotic patients in a referral liver unit Am J Gastroenterol 2001 96 1581 6
2. Violi F Ferro D Basili S et al. Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis Hepatology 1992 15 672 6
3. Violi F Alessandri C Ferro D et al. Interrelation between factor VII, prekallikrein, and hyperfibrinolysis in advanced cirrhosis J Clin Pathol 1989 42 1246 9
4. Chakrabarti M Bielawiec JF Evans JF et al. Methodological study and a recommended technique for determining the euglobulin lysis time J Clin Pathol 1968 21 698 701
5. Brodsky I Dennis LH Evaluation of fibrinolysis in hepatic cirrhosis. Relation of serial thrombin time and euglobulin lysis time Am J Clin Pathol 1996 45 61 9
6. Amitrano L Guardascione MA Brancaccio V et al. Coagulation disorders in liver disease Semin Liver Dis 2002 22 83 96
7. Booth NA Anderson JA Bennet B Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator J Clin Pathol 1984 37 772 7
8. Tran-Thang C Fasel-Felley J Pralong G et al. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis Thromb Haemost 1989 62 651 3
9. Marongiu F Mamusa AM Mameli C et al. Alpha2-antiplasmin and disseminated intravascular coagulation in liver cirrhosis Thromb Res 1985 37 287 94
10. Van Thiel DH George M Fareed J Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease Thromb Haemost 2001 85 667 70
11. Colucci M Binetti BM Branca MG et al. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis Hepatology 2003 38 230 7
12. Sakharov D Plow EF Rijken DC On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B J Biol Chem 1997 272 14477 82
13. Wang W Boffa M Bajzar L et al. A study on the mechanism of activated thrombin-activatable fibrinolysis inhibitor J Biol Chem 1998 273 27176 81
14. Steib A Gengenwin AS Freys G et al. Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients Br J Anaesth 1994 73 645 8
15. Boks AL Brommer EJ Schalm SW et al. Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage Hepatology 1986 6 79 86
16. Garcia-Tsao G Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis Gastroenterology 2001 120 726 48
17. Violi F Basili S Ferro D et al. Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients Thromb Haemost 1996 76 177 83
18. Mannucci PM Hemostatic drugs NEJM 1998 339 245 53
19. Hunt BJ Segal H Hyperfibrinolysis J Clin Pathol 1996 49 958
20. Teufelsbauer H Proidl S Havel M et al. Early activation of haemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis Thromb Haemost 1992 68 250 2
21. DelRossi AJ Cernaianu AC Botros S et al. Prophylactic treatment of postperfusion bleeding using EACA Chest 1989 96 27 30
22. Daily PO Lamphere JA Dembitsky WP et al. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting: a randomized, prospective, double-blind study J Thorac Cardiovasc Surg 1994 108 99 106
23. Vander Salm TJ Kaur S Lancery RA et al. Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid J Thorac Cardiovasc Surg 1996 112 1098 107
24. Bennett-Guerrero E Sorohan JG Gurevich ML et al. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: A randomized, blinded clinical trial Anesthesiology 1997 87 1373 80
25. Munoz JJ Birkmeyer NJ O'Connor GT et al. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery? A meta-analysis Circulation 1999 99 81 9
26. Erstad BL Antifibrinolytic agents and desmopressin as hemostatic agents in cardiac surgery Ann Pharmacother 2001 35 1075 84
27. Porte RJ Bontempo FA Knot EAR et al. Systemic effects of tPA associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation Transplantation 1989 47 978 84
28. Kang Y Lewis JH Navalgund A et al. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation Anesthesiology 1987 66 766 73
29. Fanashawe MP Shore-Lesserson L Reich DL Two cases of fatal thrombosis after aminocaproic acid therapy and deep hypothermic circulatory arrest Anesthesiology 2001 95 1525 7
30. Pitts TO Spero JA Bontempo FA et al. Acute renal failure due to high-grade obstruction following therapy with epsilon-aminocaproic acid Am J Kidney Dis 1986 8 441 4
31. Hayhurst MD Extensive thrombosis following central venous catheterization - a relationship to antifibrinolytic therapy S Afr Med J 1983 63 797
32. McNicol GP Fletcher AP Alkjaersig N et al. The absorption, distribution, and excretion of ε-aminocaproic acid following oral or intravenous adminstration to man J Lab Clin Med 1962 59 15 24